| Logan Skelley, MD | |
|
40 W 14th St Ste 3, Helena, MT 59601-3385 | |
| (406) 272-5941 | |
| Not Available |
| Full Name | Logan Skelley |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 10 Years |
| Location | 40 W 14th St Ste 3, Helena, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851710727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 76552 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guardian Dermatology | 8820488968 | 3 |
News Archive
A new standardized approach for feeding infants in the neonatal intensive care unit (NICU) helps babies attain full oral feeds sooner, improves their growth and sends them home sooner.
The Else Kröner Fresenius Center (EKFZ) for Digital Health of the TU Dresden and the University Hospital Carl Gustav Carus is researching the use of context-sensitive data glasses in everyday clinical practice in cooperation with tooz technologies.
Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra's drug discovery platform, Pharmacomer Technology.
UL (Underwriters Laboratories), a global safety science company, announced today it is entering into a relationship with world-renown toxicologists and researchers to develop a cutting-edge tool to predict the toxicity of chemicals.
› Verified 5 days ago
| Entity Name | Guardian Dermatology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972172328 PECOS PAC ID: 8820488968 Enrollment ID: O20211206000684 |
News Archive
A new standardized approach for feeding infants in the neonatal intensive care unit (NICU) helps babies attain full oral feeds sooner, improves their growth and sends them home sooner.
The Else Kröner Fresenius Center (EKFZ) for Digital Health of the TU Dresden and the University Hospital Carl Gustav Carus is researching the use of context-sensitive data glasses in everyday clinical practice in cooperation with tooz technologies.
Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra's drug discovery platform, Pharmacomer Technology.
UL (Underwriters Laboratories), a global safety science company, announced today it is entering into a relationship with world-renown toxicologists and researchers to develop a cutting-edge tool to predict the toxicity of chemicals.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Logan Skelley, MD 40 W 14th St Ste 3, Helena, MT 59601-3385 Ph: (406) 272-5941 | Logan Skelley, MD 40 W 14th St Ste 3, Helena, MT 59601-3385 Ph: (406) 272-5941 |
News Archive
A new standardized approach for feeding infants in the neonatal intensive care unit (NICU) helps babies attain full oral feeds sooner, improves their growth and sends them home sooner.
The Else Kröner Fresenius Center (EKFZ) for Digital Health of the TU Dresden and the University Hospital Carl Gustav Carus is researching the use of context-sensitive data glasses in everyday clinical practice in cooperation with tooz technologies.
Kadmon Pharmaceuticals LLC, and Nano Terra, Inc., today announced that they have entered into an agreement under which Kadmon has been granted a perpetual, worldwide exclusive license to three novel, clinical-stage product candidates owned by Nano Terra as well as rights to Nano Terra's drug discovery platform, Pharmacomer Technology.
UL (Underwriters Laboratories), a global safety science company, announced today it is entering into a relationship with world-renown toxicologists and researchers to develop a cutting-edge tool to predict the toxicity of chemicals.
› Verified 5 days ago
Ms. Debra J Remillard, PAC Dermatology Medicare: Medicare Enrolled Practice Location: 50 South Last Chance Gulch, Ste 3, Helena, MT 59601 Phone: 406-442-3534 Fax: 406-442-2064 | |
Dr. Stephen D Behlmer, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 50 South Last Chance Gulch, Ste 3, Helena, MT 59601 Phone: 406-442-3534 Fax: 406-442-2064 | |
Latha Sree Vellanki, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Dr, Helena, MT 59601 Phone: 406-443-7200 Fax: 406-443-7201 | |
Byron David Baldridge, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Dr # 201b, Helena, MT 59601 Phone: 406-443-7200 Fax: 406-443-7201 | |
Dr. Jeffry Andrew Goldes, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 South Last Chance Gulch, Ste 3, Helena, MT 59601 Phone: 406-442-3534 Fax: 406-442-2064 |